Deepinder Goyal’s Temple doubles valuation to $375m after secondary sale

Wellness wearable startup Temple has doubled its valuation from about $190 million to $375 million through a secondary transaction and launched its first ESOP liquidity programme. Its forehead-worn metabolic monitor remains in early access, with a commercial launch targeted within a year.

— Source publishedMon, 27 Jul, 2026, 14:07 IST·First seen Mon, 27 Jul, 2026, 14:09 IST·Source Entrackr · Newsletter

What happened

Deepinder Goyal-founded wellness wearable startup Temple doubled its valuation to $375 million through a secondary sale and launched its first ESOP liquidity

Key facts

  • $375 million latest valuation
  • ~$190 million previous valuation
  • $54 million previously raised
  • 9 startups
  • more than $270 million ESOP buybacks in 2026
  • Rs 20 crore Scapia ESOP buyback

Why this matters

Temple’s forehead-worn metabolic monitor could become a strategic partnership or acquisition target for health, fitness and consumer-tech platforms seeking differentiated wellness data.

What to watch

  • Confirmation of commercial launch timing, final retail price and geographic availability.
  • Evidence of sensor accuracy, correlation with established metabolic measures and any clinical or regulatory validation.
  • Early-access retention, daily wear time, referral rates and conversion from trial users to paid subscriptions.
  • Whether Temple announces recurring-revenue products, coaching services or food and fitness integrations.
  • Manufacturing, battery, comfort or supply-chain disclosures that could affect launch readiness.
  • New funding versus additional secondary sales, which would distinguish growth-capital needs from shareholder liquidity.
  • Competitive moves by CGM makers, smart-ring brands, smartwatch platforms and preventive-health apps.
  • Use the ESOP liquidity programme to retain technical, clinical, hardware and data-science talent ahead of launch.
  • Expand early-access cohorts to generate validation data, testimonials and evidence on whether readings change consumer behavior.
  • Prioritize manufacturing readiness, device reliability and customer-support infrastructure for a launch targeted within a year.
  • Build a monetization stack around software insights, coaching, nutrition and fitness integrations rather than relying solely on device sales.
  • Clarify clinical claims, data-privacy policies and any regulatory pathway before broad consumer marketing.
  • Pursue distribution partnerships with premium wellness, preventive-health, fitness and corporate-benefits channels.

Also reported by